Conleth (@conlethmurphy) 's Twitter Profile
Conleth

@conlethmurphy

ID: 2223090287

calendar_today13-12-2013 09:23:28

335 Tweet

362 Takipçi

120 Takip Edilen

curepodcast (@curepodcast) 's Twitter Profile Photo

Today we chat to the mighty Stefan Okunbor. He is currently a member of the Kerry Senior football panel. He speaks openly about his experience of growing up black in Ireland, racism, his travels to Australia to peruse an AFL career, injury set backs & more. #gaa #Diversity

Today we chat to the mighty Stefan Okunbor. He is currently a member of the Kerry Senior football panel. He speaks openly about his experience of growing up black in Ireland, racism, his travels to Australia to peruse an AFL career, injury set backs & more. #gaa #Diversity
curepodcast (@curepodcast) 's Twitter Profile Photo

Stefan was incredibly generous to speak so frankly about his experiences. We hope you enjoy the show. Available at open.spotify.com/episode/0KsRbf…. #racism #inclusion #sport #Kerry #podcast

Conleth (@conlethmurphy) 's Twitter Profile Photo

Congrats ⁦Austin Duffy⁩, great article about a great writer. Austin Duffy: ‘I wanted to immerse the reader in the terror of being on call’ theguardian.com/books/2022/jul…

Bon Secours Cork Cancer Centre (@bonscancercork) 's Twitter Profile Photo

Busy day for the Oncology clinical trials team, delighted to treat our first patient on the Piccolo trial today, investigating Mirvetuximab Soravtansine in platinum sensitive recurrent #ovariancancer #cancer #Clinicaltrial #research UCC Cancer Trials Group ImmunoGen Conleth

ONCOassist® | The go-to oncology app (@oncoassist) 's Twitter Profile Photo

Listen to the host of the REACH podcast & the director of the exercise oncology lab @CiaranFairman We discussed the academic evidence & publications that support the benefits of exercise in cancer care & much more: bit.ly/CiaranFairman #OncTwitter #OncoAlert #OncEd

Listen to the host of the REACH podcast & the director of the exercise oncology lab @CiaranFairman

We discussed the academic evidence & publications that support the benefits of exercise in cancer care & much more: bit.ly/CiaranFairman 

#OncTwitter #OncoAlert #OncEd
stuierow (@stuierow) 's Twitter Profile Photo

Great day today Bon Secours Cork Cancer Centre - another Paxman commission and install into a very impressive oncology unit. Friendly and approachable team with a clear passion for patient care. Conleth Thank you.

Great day today <a href="/BonsCancerCork/">Bon Secours Cork Cancer Centre</a> - another <a href="/scalpcooling/">Paxman</a> commission and install into a very impressive oncology unit. Friendly and approachable team with a clear passion for patient care. <a href="/conlethmurphy/">Conleth</a> Thank you.
curepodcast (@curepodcast) 's Twitter Profile Photo

Hello friends! We have a super episode to open Season 3. We talk to Richard Hogan, pyschotherapist, columnist and author of Parenting the Screenager. He tells us all about the challenges of parenting, how to navigate those tricky teenage years & develop skills to manage adversity

Hello friends! We have a super episode to open Season 3. We talk to Richard Hogan, pyschotherapist, columnist and author of Parenting the Screenager. He tells us all about the challenges of parenting, how to navigate those tricky teenage years &amp; develop skills to manage adversity
curepodcast (@curepodcast) 's Twitter Profile Photo

We were delighted to talk to Fulbright scholar Conor Hammersley about his research on #masculinity in modern Ireland. In Part 1 he describes the historical & cultural backdrop underpinning masculine identity in Ireland. Listen here: is.gd/6iKJq7 #MensHealth #Fulbright

We were delighted to talk to Fulbright scholar Conor Hammersley about his research on #masculinity in modern Ireland. In Part 1 he describes the historical &amp; cultural backdrop underpinning masculine identity in Ireland. Listen here: is.gd/6iKJq7 #MensHealth #Fulbright
Bon Secours Cork Cancer Centre (@bonscancercork) 's Twitter Profile Photo

Busy day for the Oncology Clinical Trials team, delighted to treat our first patient on the MK3475-C93 trial today, investigating Pembrolizumab vs. Platinum doublet chemotherapy in dMMR Advanced or Recurrent Endometrial Cancer #endometrialcancer #clinicaltrial #cancer #research

Busy day for the Oncology Clinical Trials team, delighted to treat our first patient on the MK3475-C93 trial today, investigating Pembrolizumab vs. Platinum doublet chemotherapy in dMMR Advanced or Recurrent Endometrial Cancer #endometrialcancer #clinicaltrial #cancer #research
Conleth (@conlethmurphy) 's Twitter Profile Photo

Frustrating to see discussion (and/or tacit endorsement) of treatments unsupported by evidence at #ASCO24 . At the endometrial cancer session 40% of the audience voted to give trastuzumab deruxtecan to a patient with HER2 2+ IHC. This should be called out more strongly!

Bon Secours Cork Cancer Centre (@bonscancercork) 's Twitter Profile Photo

Excited to share the news that our cancer centre has been officially certified by ASCO 🎉 Patient-centred care is our focus, and we’re proud to meet expert-backed oncology medical home standards. A great start to #WorldCancerDay 🌎🎗️. Thank you ASCO Irish Cancer Society

Excited to share the news that our cancer centre has been officially certified by ASCO 🎉 Patient-centred care is our focus, and we’re proud to meet expert-backed oncology medical home standards. A great start to #WorldCancerDay 🌎🎗️. Thank you <a href="/ASCO/">ASCO</a> <a href="/IrishCancerSoc/">Irish Cancer Society</a>
Bon Secours Cork Cancer Centre (@bonscancercork) 's Twitter Profile Photo

1️⃣ First patient randomized in the MK2870-010 trial offering Sacituzumab Tirumotecan alone or in combination with Pembrolizumab vs. Standard treatment for unresectable locally advanced/MBC! 🎉 👏 Huge thanks to our team & brave patients for reaching this milestone

1️⃣ First patient randomized in the MK2870-010 trial offering Sacituzumab Tirumotecan alone or  in combination with Pembrolizumab vs. Standard treatment for unresectable locally advanced/MBC! 🎉
👏 Huge thanks to our team &amp; brave patients for reaching this milestone
Bon Secours Cork Cancer Centre (@bonscancercork) 's Twitter Profile Photo

2️⃣ 2nd patient randomised on the MK2870-012 trial! 🎉 Grateful for our dedicated team and courageous patients in contributing to advancing new treatment options ✨Conleth 💡trial details: merckclinicaltrials.com/trial/nct06393…